Get the Stockscreener App
2.765
0.54%
-0.015
Ccc Intelligent Solutions Holdings Inc stock is traded at $2.765, with a volume of 2.36M.
It is down -0.54% in the last 24 hours and down -19.86% over the past month.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.
See More
Previous Close:
$2.78
Open:
$2.78
24h Volume:
2.36M
Relative Volume:
0.93
Market Cap:
$340.16M
Revenue:
$34.86M
Net Income/Loss:
$-103.80M
P/E Ratio:
-2.3345
EPS:
-1.1844
Net Cash Flow:
$-96.02M
1W Performance:
-12.50%
1M Performance:
-19.86%
6M Performance:
-4.66%
1Y Performance:
+11.49%
1-Day Range:
$2.695
$2.81
1-Week Range:
$2.59
$3.30
52-Week Range:
$1.6901
$5.17
Ccc Intelligent Solutions Holdings Inc Stock (CCCC) Company Profile
Name
Ccc Intelligent Solutions Holdings Inc
Sector
Industry
Phone
(617) 231-0700
Address
490 ARSENAL WAY, WATERTOWN
Compare CCCC vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CCCC
Ccc Intelligent Solutions Holdings Inc
|
2.765 | 340.16M | 34.86M | -103.80M | -96.02M | -1.1844 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Ccc Intelligent Solutions Holdings Inc Stock (CCCC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-09-26 | Initiated | JP Morgan | Overweight |
| Dec-02-25 | Initiated | TD Cowen | Buy |
| Sep-17-25 | Initiated | Barclays | Overweight |
| Sep-15-25 | Upgrade | Stephens | Equal-Weight → Overweight |
| Sep-04-25 | Initiated | Guggenheim | Buy |
| Dec-19-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-18-24 | Initiated | Stephens | Equal-Weight |
| Jan-29-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Dec-13-23 | Upgrade | Stifel | Hold → Buy |
| Feb-24-23 | Upgrade | Credit Suisse | Underperform → Neutral |
| Feb-24-23 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-04-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-11-22 | Initiated | Morgan Stanley | Underweight |
| Apr-28-22 | Initiated | Credit Suisse | Underperform |
| Apr-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-10-22 | Initiated | JP Morgan | Overweight |
| Feb-11-22 | Resumed | BMO Capital Markets | Outperform |
| Feb-10-22 | Initiated | Wells Fargo | Equal Weight |
| Nov-23-21 | Initiated | BofA Securities | Buy |
| Oct-14-21 | Initiated | SVB Leerink | Mkt Perform |
| Sep-30-21 | Initiated | Stifel | Hold |
| Jun-04-21 | Initiated | H.C. Wainwright | Buy |
| Mar-31-21 | Initiated | BMO Capital Markets | Outperform |
| Oct-28-20 | Initiated | UBS | Buy |
| Oct-27-20 | Initiated | BMO Capital Markets | Outperform |
| Oct-27-20 | Initiated | Jefferies | Buy |
View All
Ccc Intelligent Solutions Holdings Inc Stock (CCCC) Latest News
Nurix Therapeutics, Inc. (NRIX) Stock Price, News, Quote & History - Yahoo Finance
Is MacroGenics (MGNX) Stock Outpacing Its Medical Peers This Year? - Zacks Investment Research
C4 Therapeutics Director Donna Roy Grogan Receives 4,618 Shares Instead of Cash Compensation - Kalkine Media
Shares replace cash pay as C4 Therapeutics (CCCC) director receives 3,662 shares. - Stock Titan
Director receives 4,618 shares instead of cash compensation at C4 Therapeutics (CCCC) - Stock Titan
C4 Therapeutics Inc (CCCC-Q) Stock Price and News - The Globe and Mail
Form 4 C4 Therapeutics Inc For: 27 September By Investing.com - Investing.com Nigeria
Form 4 C4 Therapeutics Inc For: 27 September By Investing.com - Investing.com India
Form 8K C4 Therapeutics Inc For: 25 September By Investing.com - Investing.com Canada
C4 Therapeutics Presents New Biomarker Data from the Cemsidomide Phase 1 Trial with Dexamethasone and Phase 1b Trial with Elranatamab in Relapsed/Refractory Multiple Myeloma at the 23rd International Myeloma Society Annual Meeting - Investing News Network
C4 Therapeutics presents cemsidomide trial biomarker data - Investing.com
C4 Therapeutics Reports Phase 1 Cemsidomide Biomarker Data Showing T-Cell Activation and Advances Elranatamab Combination Trial - Quiver Quantitative
C4 Therapeutics: 53% of 20 respond at trial dose - Stock Titan
C4 Therapeutics Presents New Biomarker Data from the Cemsidomide Phase 1 Trial with Dexamethasone and Phase 1b Trial with Elranatamab (ELREXFIO®) in Relapsed/Refractory Multiple Myeloma at the 23rd International Myeloma Society (IMS) Annual Meeting - GlobeNewswire Inc.
In two patients with blood cancer, tests suggest a drug combo may keep immune cells from wearing out. - Stock Titan
C4 Therapeutics Presents New Biomarker Data from the - GlobeNewswire
Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year? - Yahoo Finance
C4 Therapeutics (NASDAQ: CCCC) CFO logs RSU shares, withholds stock for taxes - Stock Titan
C4 Therapeutics (Nasdaq:CCCC)Stock Analysis - Simply Wall Street
CCC Intelligent Solutions Holdings Inc. Common Stock $CCC Shares Sold by Amundi - MarketBeat
Copart to buy ACV Auctions in $1.9 billion deal - Reuters
Copart earnings up next amid CCC deal talks, growth strategy test - investing.com
CCC Intelligent Solutions Holdings Inc. (CCC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Eastern Progress
Wellington Management Group LLP Invests $17.87 Million in CCC Intelligent Solutions Holdings Inc. Common Stock $CCC - MarketBeat
C4 Therapeutics: Priced For Perfection Ahead Of 2027 Cemsidomide Readouts (NASDAQ:CCCC) - Seeking Alpha
C4 Therapeutics to Present New Biomarker Data on the Immunomodulatory Effects of Cemsidomide in Combination with Dexamethasone from its Phase 1 Relapsed/Refractory Multiple Myeloma Trial at the 23rd International Myeloma Society Annual Meeting - Investing News Network
CCC Intelligent Solutions Holdings Inc. Common Stock $CCC Shares Purchased by Ancora Advisors LLC - MarketBeat
Susquehanna Fundamental Investments LLC Cuts Holdings in CCC Intelligent Solutions Holdings Inc. Common Stock $CCC - MarketBeat
CCC Intelligent Solutions Holdings Inc. Common Stock $CCC Shares Purchased by Thornburg Investment Management Inc. - MarketBeat
Could Copart (CPRT) Stock Gain from a Transformative Deal for CCC Intelligent Solutions (CCC)? - Yahoo Finance
CCC on reported talks of selling company - repairerdrivennews.com
Analysts Offer Insights on Technology Companies: CCC Intelligent Solutions Holdings (CCC) and Lsi Industries (LYTS) - The Globe and Mail
CCC Intelligent Solutions Holdings Inc. Common Stock (NASDAQ:CCC) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Analysts Offer Insights on Technology Companies: nCino (NCNO), Salesforce (CRM) and Hon Hai Precision Industry (OtherHNHPF) - The Globe and Mail
Are You Looking for a Top Momentum Pick? Why C4 Therapeutics, Inc. (CCCC) is a Great Choice - Yahoo Finance
Car-Seller Copart Is Among Suitors for Software Firm CCC - Yahoo Finance
CCC (CCC) Today: Finishes 3.78% Higher at $7.41; Market Levels: Price Remains Between $7.04 Support and $7.78 Resistance for the Current SessionCall Spread Alert - Vinanet
Copart Reportedly In Talks To Acquire CCC Intelligent Solutions - Auto Recycling World
Car-Seller Copart Among Suitors for Car Insurance Software Firm CCC - Claims Journal
Watch Car-Seller Copart Is Among Suitors for Software Firm CCC - Bloomberg.com
Why CCC Intelligent Solutions Stock Rose Today - Moomoo
Why CCC Intelligent Solutions Stock Rose Today - Quiver Quantitative
Longtime Chicago auto tech firm CCC draws takeover interest - Crain's Chicago Business
CCC Intelligent Solutions gains on report of Copart takeover talks - Seeking Alpha
Car-Seller Copart Is Among Suitors for Car Insurance Software Firm CCC - Bloomberg.com
CCC Intelligent (NYSE: CCC) investor to sell 368,930 shares - Stock Titan
T. Rowe Price (CCC) discloses 7.5% beneficial stake in CCC Intelligent Solutions - Stock Titan
RA Capital discloses 9.99% C4 Therapeutics (CCCC) stake with warrant blockers - Stock Titan
Earnings Beat: C4 Therapeutics, Inc. (NASDAQ:CCCC) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - Simply Wall Street
CCC Intelligent Solutions Holdings Inc. (NASDAQ:CCC) - intelligentinvestor.com.au
Ccc Intelligent Solutions Holdings Inc Stock (CCCC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Ccc Intelligent Solutions Holdings Inc Stock (CCCC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| JAY GELDMACHER | Former REZI CEO |
Aug 14 '26 |
Proposed Sale |
23.01 |
82,563 |
1,899,926 |
0 |
| Mark Mossler | Officer |
Aug 13 '26 |
Proposed Sale |
4.07 |
15,000 |
61,072 |
0 |
| Mark Mossler | Officer |
Aug 12 '26 |
Proposed Sale |
3.93 |
19,519 |
76,680 |
0 |
| Anderson Kenneth Carl | Director |
Jun 01 '26 |
Option Exercise |
2.11 |
1,070 |
2,258 |
69,300 |
| Mark Mossler | Former Section 16 Officer |
May 27 '26 |
Proposed Sale |
3.91 |
9,087 |
35,485 |
0 |
| JOLIE M SIEGEL | Officer |
Mar 09 '26 |
Proposed Sale |
3.74 |
101,175 |
378,849 |
0 |
| REYNO LEONARD | Chief Medical Officer |
Jan 16 '26 |
Sale |
2.22 |
10,000 |
22,200 |
156,382 |
4.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):